嘉澤新能(601619.SH):寧夏嘉澤同心縣韋州鎮100MWp平價複合光伏項目完成備案
格隆匯 10 月 13日丨嘉澤新能(601619.SH)公佈,公司全資子公司寧夏順博新能源有限公司於2020年10月12日收到寧夏回族自治區發展和改革委員會出具的《寧夏回族自治區企業投資項目備案證》。現將相關情況公告如下:
項目代碼:2020-640324-44-03-011502,項目名稱:寧夏嘉澤同心縣韋州鎮100MWp平價複合光伏項目,項目法人全稱:寧夏順博新能源有限公司,建設地點:吳忠市同心縣韋州鎮,建設性質:新建,計劃開工時間:2021年3月,項目總投資:3.2億元,建設規模:100MWp。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.